| Ytd | 150.28% | |
| 1y | 205.09% |
| Open | 48.57 | Prev Close | 47.75 | Low | 46.53 | High | 49.90 | Mkt Cap | 4.37B |
| Vol | 1.08M | Avg Vol | 1.08M | EPS | -1.54 | P/E | N/A | Forward P/E | 78.94 |
| Beta | 0.71 | Short Ratio | 2.68 | Inst. Own | 53.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 01-29 | Earning | 11-06 | 50-d Avg | 41.83 | 200-d Avg | 30.81 | 1yr Est | 47.40 |
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation fi
LOS ANGELES--(BUSINESS WIRE)---- $CLMT--CLMT Investors Have Opportunity to Join Calumet, Inc. Fraud
BlackRock Inc. boosted its position in Calumet, Inc. (NASDAQ: CLMT) by 5.1% during the second quarte
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
UBS analyst Manav Gupta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price targe
INDIANAPOLIS, Aug. 25, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today
On August 18, 2026, Calumet Inc (CLMT) shares rose 5.1% today, reaching a current price of $50.81. T
Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the pr
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and raises the price
Calumet (CLMT) delivered a strong Q2, with adjusted EBITDA of $159M versus $116M estimates, driven b
Bank of America raised its price target on Calumet stock. Stronger free cash flow enabled the compan
BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained
Calumet, Inc. (CLMT) Q2 2026 Earnings Call Transcript
The company posted a surprise net loss in its second quarter.
Calumet NASDAQ: CLMT reported second-quarter adjusted EBITDA with tax attributes of $175 million, as
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(1.09) per share which missed th
Second Quarter 2026 net loss of $(95.9) million, or basic earnings per common share of $(1.09), driv
Does Calumet, Inc. (CLMT) have what it takes to be a top stock pick for momentum investors? Let's fi
ST. PAUL, Minn., Aug. 4, 2026 /PRNewswire/ -- Montana Renewables, LLC (MRL) joined the Minnesota SAF
Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the pr
Energy stocks like CLMT, WES, HP and RIG have the potential to deliver better-than-expected Q2 earni
Here is how Calumet, Inc. (CLMT) and Kosmos Energy (KOS) have performed compared to their sector so
INDIANAPOLIS, July 23, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet,"
Does Calumet, Inc. (CLMT) have what it takes to be a top stock pick for momentum investors? Let's fi
Here is how Calumet, Inc. (CLMT) and Kosmos Energy (KOS) have performed compared to their sector so
Energy stocks flashing warning for momentum investors. RSI, a momentum indicator, shows overbought v
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(3.64) per share which missed th
U.S. gasoline crosses $4 a gallon and diesel posts its best month ever as the Iran war widens crack
Dow Jones index up 400 points. IQIYI rose on buyback & HK listing. CODI, UTHR, SGML, CLMT, TRON,
Top analysts changed ratings for OVV, ALMS, CLMT, LGN, RCKT, UTHR, VNT, HOOD. See full changes at be
HC Wainwright & Co. analyst Amit Dayal maintains Calumet (NASDAQ:CLMT) with a Buy and raises
Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price
TRUFUEL®, an industry leader in precision-engineered fuel, has achieved the highest monthly sales vo
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(0.43) per share which met the a
Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price
Calumet, Inc. (NASDAQ:CLMT) (the "Company" or "Calumet") today announced that, subje
HC Wainwright & Co. analyst Amit Dayal reiterates Calumet (NASDAQ:CLMT) with a Buy and mainta
Goldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Buy and raises the price
Calumet, Inc. (NASDAQ:CLMT) ("Calumet, ""we," "our" or "us") provide
UBS analyst Manav Gupta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price targe
Calumet, Inc. (NASDAQ:CLMT) ("Calumet" or the "Company") announced today that it has